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Abstract
ErbB4 is a growth factor receptor tyrosine kinase essential for neurodevelopment. Genetic variation in ErbB4 is associated
with schizophrenia and risk-associated polymorphisms predict overexpression of ErbB4 CYT-1 isoforms in the brain in the
disorder. The molecular mechanism of association is unclear because the polymorphisms flank exon 3 of the gene and
reside 700 kb distal to the CYT-1 defining exon. We hypothesized that the polymorphisms are indirectly associated with
ErbB4 CYT-1 via splicing of exon 3 on the CYT-1 background. We report via cloning and sequencing of adult and fetal
human brain cDNA libraries the identification of novel splice isoforms of ErbB4, whereby exon 3 is skipped (del.3). ErbB4
del.3 transcripts exist as CYT-2 isoforms and are predicted to produce truncated proteins. Furthermore, our data refine the
structure of the human ErbB4 gene, clarify that juxtamembrane (JM) splice variants of ErbB4, JM-a and JM-b respectively, are
characterized by the replacement of a 75 nucleotide (nt) sequence with a 45-nt insertion, and demonstrate that there are
four alternative exons in the gene. Our analyses reveal that novel splice variants of ErbB4 exist in the developing and adult
human brain and, given the failure to identify ErbB4 del.3 CYT-1 transcripts, suggest that the association of risk
polymorphisms in the ErbB4 gene with CYT-1 transcript levels is not mediated via an exon 3 splicing event.
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Introduction
Alternative splicing is a key element in gene regulation that
increases proteome diversity and the coding potential of the
human genome. Evidence from expressed sequence tag, cDNA,
genome-wide tiling and splicing microarray datasets demonstrate
that alternative splicing occurs in .90% of genes [1–3].
Alternative splicing is especially prevalent in the brain which
may account for the high incidence of genetic brain disorders.
Linkage and association analyses have identified neuregulin 1
and its receptor ErbB4 as susceptibility genes for schizophrenia
[4–7] and recently partial deletions of the ErbB4 gene have been
reported in the disorder [8]. ErbB4 is a member of the receptor
tyrosine kinase family, which also includes epidermal growth factor
receptor (EGFR/HER1/ErbB1), HER2/ErbB2, and HER3/
ErbB3. The human ErbB4 gene spans 1.16 Mb (megabases) on
chromosome 2q34 and has been annotated to consist of 28 exons.
To date, four structurally and functionally distinct splice isoforms
of the human ErbB4 gene have been described. The JM-ErbB4
isoforms differ within their extracellular juxtamembrane domain
annotated as based on differential inclusion of exon 15 (JM-a) or
exon 16 (JM-b), which renders them susceptible or resistant,
respectively, to processing by matrix metalloproteases [9,10]. The
ErbB4-CYT isoforms arise from additional splicing of the
cytoplasmic tail region based on the inclusion (CYT-1) or
exclusion (CYT-2) of exon 26, encoding 16 amino acids [11].
Previous studies have demonstrated that a haplotype consisting
of three single nucleotide polymorphisms (SNPs; rs707284,
rs839523 and rs7598440) in the human ErbB4 gene is associated
with increased risk for schizophrenia, augmented expression of the
ErbB4 CYT-1 phosphoinositide 3-kinase (PI3K)-linked isoform in
the brain of patients and altered frontotemporal structural
connectivity in normal humans measured with magnetic reso-
nance imaging (MRI) techniques [6,7,12]. The mechanism by
which the risk SNPs influence ErbB4 CYT-1 expression is at
present unclear, primarily because the SNPs are intronic and
reside 700 kilobases (kb) 59 to the CYT-1 specific exon.
Interestingly, the risk SNPs flank both the 59 and 39 extent of
exon 3 and thus may have potential to affect splicing of this exon
as part of the splicing code [13].
In the present study we tested the hypothesis that ErbB4 risk
SNPs are indirectly associated with CYT-1 expression in the brain
[7] through tagging of a population of exon 3 spliced isoforms, to
which the polymorphisms are proximal. We report the identifi-
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occur on the CYT-2 isoform background, in both fetal and adult
human brain, demonstrating for the first time that the ErbB4 exon
3 is an alternative exon. Gene expression analysis reveals that
ErbB4 del.3 mRNAs in the fetal brain are primarily JM-b/CYT-2
isoforms with lower levels of JM-a/CYT-2, whereas those
expressed in the adult are exclusively JM-a/CYT-2 isoforms,
demonstrating that these splice isoforms are developmentally
regulated.
Finally, we show that JM-a and JM-b splice isoforms of ErbB4 are
distinguished by substitution of a 75-nt sequence with a 45-nt
insertion, respectively and that contrary to the original studies [9,10],
the JM-b exon maps downstream of exon 15, but upstream of exon
16. We therefore, propose to name this 45-nt sequence, exon E15b.
Both exons E15b and 16 are mutually exclusive and contrary to
earlier characterization of the gene, exon 15 is constitutive.
Together these data provide novel insight into the molecular
regulation of ErbB4 alternative splicing in human brain across
development, clarify the exon-intron structure of ErbB4 and
suggest that a mechanism underlying association of risk polymor-
phisms in ErbB4 with schizophrenia and CYT-1 expression [7]
does not involve exon 3 skipping.
Results
A del.3 transcript variant of the human ErbB4 gene is
expressed in human fetal brain
It has previously been reported that three intronic risk SNPs
(rs7598440, rs707284, rs839523) which comprise a core-risk
haplotype are associated with increased genetic risk for schizo-
phrenia and augmented expression of a family of ErbB4 CYT-1
transcripts in the brain of patients with the disorder [6,7]. The
SNPs are physically mapped to the flanking intronic regions of
exon 3 (Figure S1A) and may represent intronic cis-acting elements
of the splice code [13]. Based on this, we examined whether
transcript variants of ErbB4, with exon 3 skipped (del.3), exist in
human brain. Using a forward primer in exon 1 and two reverse
primers in exons 4 and 5, we identified in human fetal brain,
cDNA transcripts that consist of exon 1 and exon 2, spliced to
exon 4 (Figure S1B). These experiments demonstrate that exon 3
is a novel alternatively spliced exon of the ErbB4 gene.
ErbB4 del.3 transcripts exist on the CYT-2 isoform
background in human fetal brain
In order to determine whether ErbB4 del.3 transcripts expressed
in human brain exist on the CYT-1 or CYT-2 isoform background
we designed a forward primer, (E2E4_s1), which spans the junction
of exons 2 and 4 combined with reverse primers in exon 27. The
difference between the ErbB4 CYT-1 and CYT-2 isoforms lies in
exon 26, with its inclusion or exclusion, respectively. In fetal human
brain, we amplified a PCR product of approximately 2.73 kb
(Figure S2A). After cloning and sequencing 59 cDNA clones, we
confirmed that all clones had ErbB4 exon 3 skipped. Deep
sequencing of the junction of exons 2 and 4, as well as the region
between exons 25 and 27 revealed that the del.3 transcripts all have
exon 26 excluded (Figure 1). This result suggests that ErbB4 del.3
transcripts exist in the human fetal brain as del.3/CYT-2 ErbB4
isoforms.
ErbB4 del.3 exists as a del.3/JM-b/CYT-2 isoform in
human fetal brain
The coding region of full-length ErbB4 cDNA was originally
identified from sequencing of plasmids containing ErbB4 inserts
from a human MDA-MB-453 breast cancer cell line and pEV7-
HER4, from fetal human brain tissue [9]. Sequencing revealed the
existence of two ErbB4 isoforms that differed by insertion of either
23 or 13 alternative amino acids inthe extracellularjuxtamembrane
region. The 23-amino acid form was termed, JM-a, and the 13-
aminoacidform,JM-b.Thesesequenceswerelatermappedtoexon
16 and exon 15 of the human ErbB4 gene (10), whereby JM-a was
ascribed to exon 16, and its alternative sequence JM-b, to exon 15.
We have demonstrated that the del.3/CYT-2 isoform, but not
the del.3/CYT-1 isoform, exist in human fetal brain. In order to
determine whether del.3/CYT-2 transcripts exist as JM-a or JM-b
isoforms we deep sequenced the region between exons 5 and 24 in
del.3/CYT-2 derived clones, paying particular attention to the
sequences between the exons 14 and 17. We observed that exon
16 was skipped in all del.3/CYT-2 transcripts sequenced from
fetal brain, demonstrating that del.3/CYT-2 variants in fetal brain
exist primarily as JM-b transcripts (Figure 2). Interestingly, in
contrast to the original published ErbB4 sequence and exon
structure [10], we observed one major difference. Sequencing of
the ErbB4 coding region of del.3/JM-b/CYT-2 revealed a 45-nt
insert, which is homologous to the sequence encoding 14 amino
acids [CIGSSIEDCIGLMD], specific to the JM-b isoform
(Figure 3; Figure S3A). However, this insertion represents an
alternative exon located 39 of exon 15 (Figure S3A). The physical
location of the JM-b insertion is shown in Figure 2.
Human ErbB4/JMb isoforms are defined by inclusion of a
45-nt exon (E15b) encoding 14 amino acids
The ErbB4/JM-b isoform was originally defined by an in-frame
alteration in which 69-nt in the extracellular juxtamembrane
Figure 1. Organization of the ErbB4 del.3/CYT-2 transcript cloned from the human fetal brain. Horizontal lines with ‘‘//’’ sign represent
exons from E6 to E23. Exons are shown in the order in which they occur in the transcript. The skipped exons are indicated. The length of each exon is
not drawn to scale The PCR primers are indicated as forward or reverse bent arrows, respectively. Names of the primers are shown.
doi:10.1371/journal.pone.0012924.g001
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of 39-nt (9). These sequences were later mapped to exon 16 or exon
15 of the ErbB4 gene, respectively [10]. Detailed visual analysis of
our sequences (Figure S3A) and mapping to the human genome
using the NCBI and UCSC databases (Assembly; Mar.2006
NCBI36/hg18), reveals that a 45-nt sequence specific for the JM-
b isoform does not match to any sequence inexon 15 (155 bp)of the
human ErbB4 gene (NM_005235.2). Instead, this 45-nt sequence is
100% identical to a downstream region in intron 15 (Figure 3A).
Specifically, this sequence is located close to the 39 end of ErbB4
intron 15 (chr2: 212,725,219-212725260), and is flanked by
consensus splice sites at the 59 and 39 ends (Figure 3A). We next
compared the mRNA sequence of the JM-a/CYT-1 isoform to that
of the JM-b/CYT-1 isoform. Interestingly, in contrast to previous
reports (10) these two isoforms have identical sequences in exon 15
(Figure S3A and 3B). The only difference in sequence between the
two transcripts is that the JM-a isoform is characterized by the
insertion of a 75-nt sequence derived from exon 16, whereas JM-b is
encodedbythealternative45-nt sequence.Ourobservationthat the
JM-a specific sequence is 75-nt, rather than 69-nt, as previously
reported [9] is consistent with the current reference sequences
(NM_001042599.1, NM_005235.2).
Therefore, our sequencing data demonstrate that the human
ErbB4 JM-a or JM-b splice isoform is actually invariable in exon
15 and exon 17 (Figure 3B; Figure S3A and 3B). At the genomic
DNA level, there are two alternative exons between exons 15 and
17. Given the fact that the 45-nt sequence encoding the JM-b
isoform is present in intron 15 upstream of exon 16, and that this
45-nt can be spliced out to generate a JM-b isoform, we propose to
term this 15b (E15b) to distinguish it from the upstream
constitutive exon 15 (155 bp; Figure 3). These results clarify
which internal exon encodes the ErbB4 JM-b isoform, and
demonstrate that the ErbB4 JM-b isoform is not encoded by exon
15, which is constitutive, but is instead encoded by a downstream
alternative exon E15b, located between the exons 15 and 16
(Figure 3A). Hence, exon 15b and exon 16 are mutually exclusive
alternative exons (Figure 3B).
In addition, we demonstrate through sequencing and BLAST-
mapping to the human genome using the NCBI and UCSC
databases (Assembly; Mar.2006 NCBI36/hg18) that ErbB4 E15b
encodes 14 (rather than 13, [9]) unique amino acids specific to the
JM-b isoform, whereas exon 16 encodes 24 (rather than 23 [9])
amino acids specific to the JM-a isoform (Figure 3B). This
discrepancy appears to arise because the amino acid residue
cysteine (C) located at the N-terminus of both JM-a and JM-b was
observed to be common to both isoforms in the original study [9].
Indeed, at the amino acid level this is the case; however, the
cysteine in the JM-a isoform is encoded by the DNA sequence
TGT (UGU in mRNA), whereas the cysteine in JM-b is encoded
by TGC (UGC in mRNA; Figure 3B). This sequence is consistent
with what was reported in the original study by Elenius and
colleagues [9], but limited sequence information regarding exon-
intron structure of the human ErbB4 gene at that time, likely
contributed to the interpretation that the glycine and cysteine at
the N-terminus of JM-a or JM-b isoform were encoded by the
same constitutive exon. Our data demonstrate that, the glycine
and cysteine are encoded by separate exons (exon 15 plus exon 16;
or exon 15 plus exon 15b). The glycine and cysteine in the JM-a
isoform are located at the boundary of exons 15 and 16. These two
amino acid residues are encoded by a GG dinucleotide from exon
15, together with G TGT from exon 16. In contrast, the glycine
and cysteine in JM-b isoform are located at the boundary of exons
15 and 15b (Figure 3B).
As a result, we demonstrate that the human ErbB4 gene
contains 29, rather than 28 exons. Exons 3, 15b, 16, and 26 are
alternative and exons 15b and 16 are mutually exclusive. We have
clarified that the juxtramembrane splicing event giving rise to JM-
a and JM-b results from an in-frame alteration in which 75-nt
encoding 24 amino acids is replaced with an unrelated 45-nt
sequence encoding 14 amino acids.
ErbB4 del.3 is identified as a JM-a/CYT-2 isoform in adult
brain
We have shown through PCR screening and cloning that ErbB4
del.3 transcripts in human fetal brain are expressed exclusively on
the JM-b/CYT-2 isoform background. To determine whether the
del.3/CYT-2 transcript is expressed in the adult human brain we
performed nested PCR for amplification of the ErbB4 exon 3-
skipping transcript (Figure S2B). Sequencing of ErbB4 cDNA
clones derived from adult brain revealed that both exons 3 and 26
are skipped, similar to that found in fetal brain. Again, we did not
detect ErbB4 del.3/CYT-1 transcripts in our screen of the adult
human brain cDNA library. Interestingly, all clones also lacked
exon 15b, but included exon 16, characteristic of the JM-a isoform
(Figure S3B and S4). Therefore, in contrast to the human fetal
brain, the ErbB4 del.3 transcripts cloned in the adult brain were
preferentially expressed on the JM-a/CYT-2 isoform background.
Figure 2. The ErbB4 del.3/CYT2 variant exists as a JM-b isoform in the human fetal brain. Open boxes represent exons. The horizontal
lines with the first ‘‘//’’ sign represent exons E6 to E13. Horizontal lines with the second ‘‘//’’ sign represent exons from E18 to E23. The PCR primers are
indicated as forward or reverse bent arrows, respectively. Names of the primers are shown. The three spliced exons (exons 3, 16, and 26) are
indicated. The 14 aa sequence encoded by the 45-nt, specific for the JM-b isoform, is shown.
doi:10.1371/journal.pone.0012924.g002
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fetal human brain
RT-PCR analysis of ErbB4 del.3 mRNA expression in the adult
and fetal human brain reveals that exon 3 skipping transcripts are
readily detectable (Figure 4A and 4B). Consistent with the cloning
data, ErbB4 del.3/JMb/CYT-2 isoforms are exclusively expressed
in fetal brain and absent in the adult brain (Figure 4A). In contrast,
we identified that ErbB4 del.3/JM-a/CYT-2 mRNAs are
expressed in both adult and fetal brain (Figure 4B). The fact that
we did not identify del.3/JM-a/CYT-2 in the PCR screen of the
fetal brain library is likely due to the predominance of the del.3/
JM-b transcript. These results combined with quantitative PCR
(qPCR) analysis of overall JM-a and JM-b mRNA abundance in
adult brain vs. fetal brain (data not shown), demonstrate that
ErbB4 JM-b isoforms are differentially expressed in the fetal and
adult human brain (JM-b, fetal . adult) and that this is likely due
in part to the differential contribution of ErbB4 del.3 variants to
the JM-b isoform pool.
Semi-quantitative RT-PCR analysis of total ErbB4 del.3
mRNAs and total ErbB4 exon 3 inclusive mRNAs (ErbB4 +E3)
reveals that ErbB4 del.3 transcripts are relatively abundant in the
fetal and adult brain (Figure 4C and 4D). In human fetal brain, the
ratio of ErbB4 del.3 mRNAs to ErbB4 +E3 mRNAs is
approximately 0.71:1 and in adult brain 0.58:1, respectively
(Figure 4D). Consistent with the data described in Figure 4A and
4B, ErbB4 del.3 isoforms were more abundant in the fetal,
compared to the adult human brain (Figure 4D; ratio 1.2:1).
Open reading frame (ORF) analysis of del.3/JM-b/CYT-2
transcripts
Open reading frame (ORF) analysis predicts that omission of
the 187-nt exon 3 introduces an in-frame premature termination
Figure 3. A. Partial exon-intron structure in a region of the ErbB4 gene containing exon 15, intron 15, and exon 16. The 45-nt
sequence unique to the JM-b isoform maps to the 39 region of the intron 15, 121-nt upstream of exon 16 of the ErbB4 gene. Exons 15, 15b and 16 are
shown, respectively. Partial intronic sequences, downstream of the exon 15, upstream of the exon 16, as well as upstream and downstream of the
exon 15b are shown. Dashed lines represent intron 15 sequence. The 14 aa encoded by the 45-nt sequence, specific for the JM-b isoform, is shown.
The length of the intron 15 of the ErbB4 gene is indicated. B. Comparison of JM-a and JM-b sequences showing the nucleotide sequences specific for
JM-a or JM-b isoform and amino acids encoded by each exon. The glycine residue maps to the end of exon 15 of human ErbB4 sequence
NM_005235.2. The first cysteine is common to both JM-a and JM-b but is encoded by different nucleotide sequences belonging to exons 16 and 15b,
respectively.
doi:10.1371/journal.pone.0012924.g003
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codon in the exon 4 is predicted to create a short ORF, encoding a
C-terminal truncated peptide of 80 amino acids (Figure S5, see
ORF1). An alternative AUG triplet exists downstream of exon 4 in
exon 7 which could potentially be used to create a long ORF,
giving rise to a protein of 1033 amino acids (JM-b; Figure S5, see
ORF2) or 1043 amino acids (JM-a). N-terminal truncated ErbB4
proteins would have an identical C-terminal amino acid sequence
to the corresponding wild-type ErbB4 JM-a or JM-b/CYT-2
protein.
Discussion
In the present study, we have demonstrated that exon 3 of the
human ErbB4 gene is a novel alternative exon, and that ErbB4
exon 3-skipping splice variants are abundant in human fetal and
adult brain. Interestingly, ErbB4 del.3 transcripts are exclusively
expressed as CYT-2 isoforms. Given the absence of identification
of an ErbB4 del.3 CYT-1 transcript, we conclude that a
mechanism of association of schizophrenia-risk polymorphisms
(rs707284, rs839523 and rs7598440) to CYT-1 expression traits in
Figure 4. Expression of ErbB4 del.3/JM-b (A) and ErbB4 del.3 JM-a (B) splice isoform mRNAs in the adult and fetal human brain. For
verification purposes, dual sets of primers were used for amplification of JM-a and JM-b (as labeled). Predicted amplicon sizes: ErbB4 del.3/JM-b
(E2E4_s1 plus ErbB4_JMbas: 1489 bp, upper band and E2E4_s1 plus ErbB4_JMbE17as: 1518 bp, upper band). ErbB4 del.3 JM-a (E2E4_s1 plus
ErbB4_E15E16as: 1478 bp, upper band and E2E4_s1 plus ErbB4_E16as1: 1484 bp, upper band). Of note, additional smaller bands were detected in
the fetal brain for both del.3/JM-b and del.3/JM-a amplifications. (C) Semi-quantitative RT-PCR analysis of ErbB4 del.3 and ErbB4 +E3 mRNA
abundance in adult and fetal human brain. Amplicon sizes ErbB4 +E3 (E1_s1 plus E8_as: 1011bp). ErbB4 del.3 (E2E4_s1 plus E8_as: 578bp). (D) Mean
optical density (OD) values for ErbB4 del.3 and ErbB4 +E3 bands in adult and fetal brain. OD values for b-actin were equal across all samples.
doi:10.1371/journal.pone.0012924.g004
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skipping.
In the adult brain, del.3/CYT-2 transcripts exist exclusively as
JM-a variants and in the fetal brain as predominantly JM-b, with
lower levels of JM-a. These results indicate that JM-a and JM-b
isoforms are differentially expressed and regulated during human
neurodevelopment. At present, the mechanism and function of
exon 3 skipping is unknown. Inclusion of an alternative exon can
be influenced by interaction between trans-acting splicing regula-
tory factors and cis-acting regulatory elements in exons or introns,
such as exonic or intronic splicing enhancer/silencers and histone
methylation [13]. Additional studies are underway to address these
questions.
We observed in the human fetal brain that ErbB4 del.3
transcripts exist predominantly as JM-b/CYT-2 isoforms. A
common feature of the above transcripts is that exon 16 is
excluded, but a 45-nt sequence is included between exons 15 and
17. It has been previously shown that this sequence encodes amino
acids specific for the ErbB4 JM-b isoform [9], however, this
sequence was originally annotated to exon 15 [10]. Sequencing
and mapping analysis to current builds of the human genome
sequence reveal that this 45-nt sequence is located upstream of
exon 16, but downstream of exon 15 of the ErbB4 gene. This 45-
nt sequence comes from neither the exon 15 nor exon 16 and is
located 121-nt upstream of exon 16, flanked by consensus splice
sites. We propose to name the JM-b specific sequence, exon E15b,
to distinguish it from exon 15.
Original cloning of human ErbB4 cDNA characterized the JM-a
isoform as the inclusion of 23 amino acids (NGPTSHDCIYY-
PWTGHSTLPQHA) and the JM-b isoform as the inclusion of 13
alternative amino acids (IGSSIEDCIGLMD; [9,10]). Our findings at
the DNA sequence level for these variants are consistent to those
reported previously [9,10]. However, mapping to the current version
ofthe human genome reveals thatErbB4exon 16actuallyencodes24
amino acids (CNGPTSHDCIYYPWTGHSTLPQHA), and exon
E15b encodes 14 amino acids (CIGSSIEDCIGLMD). Although the
first amino acid from both the JM-a and JM-b isoforms is the same
(cysteine), these are actually encoded by unique nucleotide sequences
derived from different exons. Incomplete reference sequence
information and limited details of exon-intron boundaries of the
human ErbB4 gene at the time of the original cloning [9], likely
contributed to the cysteine being attributed to the same upstream
exon.
We clarify, therefore, that the ErbB4 gene consists of 29 exons;
that exon 15 is constitutive, that exons 3, 15b, 16, and 26 are
alternative and that 15b and 16 are mutually exclusive.
The potential functional significance of ErbB4 del.3 transcripts
remains to be determined. ORF analysis predicts that omission of
the 187-nt exon 3 results in the introduction of a premature
termination codon in exon 4 creating a C-terminal truncated
protein of 80 amino acids. An alternative translation initiator is
present in exon 7 and predicted to generate a protein of 1033
amino acids. Previous data suggests that a prerequisite for
downstream reinitiation of translation is the presence of a short
upstream ORF [14]. Upstream ORFs longer than 165-nt
completely abolish reinitiation of translation from a downstream
ORF [14]. Because the first ORF in the ErbB4 del.3 transcript is
240-nt in length, it is unlikely that the second AUG in exon 7
would be used as an initiator for reinitiation of translation.
Alternatively, the ‘leaky scanning mechanism’ is another way by
which two proteins can be produced from a single mRNA
transcript [15]. The leaky scanning model dictates that if the first
AUG is in a less favorable sequence context, then a fraction of 40S
ribosomal subunits will bypass the first AUG and initiate
translation at a downstream AUG. Because the AUG in the
ErbB4 exon 1 is in a good sequence context for translation
(CAAAAAAUGA), due to an ‘A’ at the 23 position and +4
positions, respectively, it is predicted that almost all ribosomes
would initiate translation at the first AUG in exon 1 Experimental
verification of this process is necessary.
Taken together, our observations suggest that ErbB4 del.3
transcripts are likely to generate a C-terminal truncated protein of
differential function to wild-type ErbB4. Alternatively, the
premature termination codon may target these transcripts for
nonsense mediated mRNA decay (NMD; [16]). However, the
abundance of full length ErbB4 del.3 mRNA transcripts in human
brain argues against such degradation. Future studies are required
to determine the contribution of ErbB4 exon 3 skipping to human
neurodevelopment and genetic diseases, but our findings suggest
that ErbB4 del.3 transcripts exist as attractive potential modulators
of ErbB4 signaling. Our findings overall have implications for
studying and understanding the role of ErbB4 in the pathogenesis
of human complex disease including neurodevelopmental disor-
ders and cancer [6–8,17].
Materials and Methods
Molecular Cloning and Sequencing of ErbB4 cDNA clones
Derived from Adult and Fetal Human Brain Libraries
RT-PCR Amplification. To determine whether exon 3 of
the ErbB4 gene is skipped in human brain, we used human fetal or
adult whole brain Marathon-Ready cDNA library (Clontech,
Mountain View, CA), respectively, as a template for PCR
amplifications. Double-stranded cDNA clones were ligated at
both ends to an adaptor that contains adaptor primer 1 (AP1) as
well as adaptor primer 2 (AP2) sequences. To determine the
expression of a del.3 transcript, we designed ErbB4 gene-specific
reverse primers in exons 4 and 5, respectively. A nested PCR
strategy was employed to screen for ErbB4 del.3 variants. Briefly,
an outer primer pair [AP1 (59-CCATCCTAATACGACTCAC-
TATAGGGC-39) and ErbB4E5_as(59-GTCCCCAGCAACGG-
CCAGTACA- 39)] was used in the first-round PCR, and sub-
sequently an inner primer pair [AP2 (59-ACTCACTATAGG-
GCTCGAGCGGC-39) and ErbB4E4_as(59-GAACTACCATTT-
GTTGACACAAGAGT-39)] was used in the second-round PCR.
First- and second-round PCRs were performed in a 50-ml final
reaction volume using the Platimun High Fidelity Taq DNA
polymerase (Invitrogen, Carlsbad, CA). PCR amplifications were
as follows: denaturation for 1 min at 94uC, annealing for 2 min at
60uC, and extension for 2 min at 68uC, with a total of 35 cycles.
For the last cycle, the PCR products were further extended for
10 min at 68uC for completion.
To determine whether ErbB4 exon 3 skipping (del.3) occurs on
the CYT-1 or CYT-2 isoform background of full length-ErbB4,
we designed a specific forward primer, E2E4_s1(59-GTTCCTG-
CGGAAATCCTAAATGGTG-39) that spans the junction of
exons 2 and 4 of the ErbB4 gene, and two reverse primers located
in the penultimate exon 27. Using a human fetal brain Marathon-
Ready cDNA library as a template, we performed first-round PCR
using an outer primer pair AP1 and reverse primer E27_as1
(59-GTATTCTTGTTTGGGTTTGTCTCGCATAGGA-39). The
second-round PCR was conducted by using an inner primer pair
E2E4_s1 and E27_as2 (59- GCAGCAAAACCTCCATCTCGG-
TATA-39). An adult human whole brain Marathon-Ready cDNA
library was used as a template for amplification of ErbB4 del.3 variants
in the adult brain. The first-round PCR was performed by using an
o u t e rp r i m e rp a i rA P 1a n dE 2 8 _ a s 1( 5 9-GACCAACCCATGCAGA-
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an inner primer pair E2E4_s1 and E27_as2.
cDNA cloning and sequencing. Amplified PCR products
were separated by electrophoresis on 1% agarose gel in 0.5x TBE,
stained with ethidium bromide and visualized under ultraviolet
light. DNA bands were dissected from the gel, and purified by the
QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA). Purified
DNA fragments were cloned into either pCR@-XL-TOPO vector
or pCR@2.1-TOPO vector using the TA-Cloning Kit (Invitrogen,
Carlsbad, CA). Two microliters of the TOPO cloning reaction was
used to transform a bacterial strain TOP10 and the resulting
colonies were grown in cultures overnight at 37uC at 225 rpm in a
shaker. The plasmid DNAs were isolated by using the QIAprep
Spin Miniprep Kit (QIAGEN, Valencia, CA). The BigDye
Terminator Kit (Applied Biosystems, Foster City, CA) was used
to determine the sequence of an insert in each plasmid with either
the M13F primer (59-GTAAAACGACGGCCAG-39) or the
M13R primer (59-CAGGAAACAGCTATGAC-39). For ErbB4
del.3 transcripts longer than 2 kb, additional primers covering
several constitutive exons of the ErbB4 gene were used for deeper
sequencing of the inserts (Table 1).
Analysis of ErbB4 del.3 JM-a/JM-b mRNA isoform
expression and ErbB4 del.3 mRNA abundance in adult
and fetal brain. To determine whether ErbB4 del.3 transcripts
with JM-a or JM-b coding regions are differentially expressed
between the human fetal and adult brain, we used Marathon-
Ready fetal or adult whole brain cDNA as a template, respectively,
and nested PCR. The first round of PCR was conducted by using
the primer pair AP1 and E28-as1 [59 -GACCAACCCATGCAG-
AGAAATGAA- 39]. Five microliters of 1:100 diluted first-round
PCR products was used in the second-round PCRs in a total
volume of 50 ml reaction. To amplify del.3/JM-b specific splice
isoforms, two primer pairs were used, respectively, in the second-
round PCRs (E2E4_s1 plus ErbB4_JMbas, and E2E4_s1 plus
ErbB4_JMbE17as; see Table S1). To amplify del.3/JM-a specific
splice isoforms, two primer pairs were used, respectively (E2E4_s1
plus ErbB4_E15E16as and E2E4_s1 plus ErbB4_E16as1; see
Table S1). Loading of gels comprised 6 ul per sample for del.3/
JM-b/CYT-2 mRNA (Figure 4A) and 20 ul per sample for del.3/
JM-a/CYT-2 mRNA (Figure 4B).
To determine the relative abundance of ErbB4 del.3 mRNAs we
performed semi-quantitative RT-PCR using primer pairs in exon 1
(E1_s1) and exon 8 (E8_as) to amplify ErbB4 + E3 mRNAs and
primer pairs spanning exon 2-exon 4 (E2-E4_s1) and exon 8 (E8_as,
see Table S1) to amplify all ErbB4 del.3 mRNAs. PCR conditions
were as described above. All PCR amplifications were carried out
under identical conditions, on the same PCR plate and during the
same reaction (b-actin was used as an internal control). Optical
density (OD) values were determined using appropriate software
(NIH Image J version 1.43, U.S. National Institutes of Health). b-
actin was measured as an internal control in all experiments. The
primers used for amplification of b-actin were bactin_E1E2s [59-
CGCCGCCAGCTCACCATGGAT-39] and bactinE3E4as [59-
TCTCAAACATGATCTGGGTCATCTT-39].
Supporting Information
Figure S1 Schematic illustration of an ErbB4 del.3 transcript of
the human ErbB4 gene. A. The 59 region of the exon-intron
structure of human ErbB4 gene is shown. Open boxes represent
exons. The horizontal lines represent the introns. A three SNP
haplotype associated with increased risk for schizophrenia is shown
with rs numbers, respectively. B. An ErbB4 del.3 transcript cloned
from human fetal brain. Open boxes represent exons.
Found at: doi:10.1371/journal.pone.0012924.s001 (1.43 MB TIF)
Figure S2 Nested PCR amplification of ErbB4 Del.3 transcripts
from fetal (A) and adult (B) human brain cDNA libraries. A. A
2.73 kb amplicon derived from fetal brain using a forward primer,
(E2E4_s1), spanning the junction of exons 2 and 4 combined with
reverse primers in exon 27. B. 2.76 kb amplicon derived from
adult brain using the forward primer, E2E4_s1 and reverse
primers in exon 27. S (sample), M (lambda DNA/HindIII
Marker).
Found at: doi:10.1371/journal.pone.0012924.s002 (0.85 MB TIF)
Figure S3 Raw sequence chromatograms showing the JM-b and
JM-a exon boundaries.
Found at: doi:10.1371/journal.pone.0012924.s003 (7.36 MB TIF)
Figure S4 ErbB4 del.3 is expressed as a JM-a/CYT-2 isoform in
the human adult brain. Open boxes represent exons. The
horizontal lines with the first ‘‘//’’ sign represent exons E6 to
E14, whereas the horizontal lines with the second ‘‘//’’ sign
represent exons E18 to E23. The PCR primers are indicated as
forward or reverse bent arrows, respectively. The three skipped
exons (exons 3, 15b, and 26) are indicated. The 24 amino acid
encoded by exon 16, specific for the JM-a isoform, is depicted.
Found at: doi:10.1371/journal.pone.0012924.s004 (4.78 MB TIF)
Figure S5 Predicted potential open reading frames (ORFs) for
translation from the ErbB4 exon 3-skipping JM-b/CYT-2 isoform.
Nucleotide positions (23 and +4) potentially affecting efficiency of
translation initiation around an AUG codon are indicated. The
position of an ‘‘A’’ in the AUG is assigned as +1. Open boxes
represent exons. The horizontal lines with the first ‘‘//’’ sign
represent the ErbB4 exons from E8 to E14, whereas the horizontal
lines with the second ‘‘//’’ sign represent exons E18 to E23.The
three skipped exons (exons 3, 16, and 26), as well as JM-b isoform
specific exon 15b are indicated. Nucleotide sequences around the
AUG in exons 1 and 7 are shown. Potential ORFs (ORF1 and
ORF2) are indicated with two-head arrows, as well as the length of
the potentially encoded amino acids.
Found at: doi:10.1371/journal.pone.0012924.s005 (5.39 MB TIF)
Table S1 Primers for RT-PCR amplifications of ErbB4 del.3
JM-a/JM-b, ErbB4 del.3 and ErbB4 +exon3 mRNAs in human
fetal and adult brains. Abbreviations: E, exon: s, sense and as,
antisense.
Found at: doi:10.1371/journal.pone.0012924.s006 (0.04 MB
DOC)
Table 1. Primers used for sequencing of ErbB4 cDNA clones.
Names of primers Primer sequences (59 --- 39)
E4_s GGAGTCTATGTAGACCAGAACAAA
E8_s GTAGAAGAAAATGGGATTAAAATGTGT
E12_s GAATAGTAATCCGGGACAACAGAAAA
E17_s GTTAGAAGGAAGAGCATCAAAAAGAAA
E21_s GGAAGGAGATGAAAAAGAGTACAAT
E5_as GTCCCCAGCAACGGCCAGTACA
E9_as GACTAGAAAGATCAAATTCCCATTGAT
E13_as GAGGTTACAAGACTCTATGCAGAT
E18_as GAGCCAAGGACTTTTACCCTCTT
E22_as AACGTCACTCTGATGGGTGAATTT
doi:10.1371/journal.pone.0012924.t001
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